Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
Logo Image
|Articles|April 5, 2019

Watson-Marlow Demonstrates Quantum Peristaltic Pump at INTERPHEX 2019

The company’s Quantum peristaltic pump uses a patented single-use cartridge technology and is applicable to downstream bioprocessing.

Watson-Marlow Fluid Technology Group (WMFTG) showcased its bioprocessing products at INTERPHEX 2019 in New York, including its Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology for downstream processing.

Quantum sets the standard for high-pressure feed pumps in SU tangential flow filtration, virus filtration (VF), and ultra-high-performance liquid chromatography, according to the company. The pump represents a step-change in pump technology for bioprocessing by enabling higher downstream process yields throughout the pressure range, delivering virtually pulse-free linear flow, lowest shear, and easy validation aligned with Biophorum Operations Group (BPOG) guidelines, WMFTG states.

Quantum delivers high accuracy with flow linearity independent of back-pressure, which removes the need for flow meters and load cells. The pump also delivers ultra-low shear, half that of diaphragm pumps, a factor that increases product viability to help maximize process yield.

Quantum is being used at Goodwin Biotechnology Inc. (GBI), a US-based, GMP contract development and manufacturing organization, to speed up completion of a purification platform for one of its customers. GBI switched to Quantum after realizing that their existing pump technology could not handle high pressures on ultrafiltration membranes for large volumes that were required. With WMFTG’s pump, GBI is able to concentrate 1500 liters of a product to 100 liters in approximately seven hours.

The ReNu SU cartridge technology used in Quantum offers validation and extractable data in line with BPOG, Bio-Process Systems Alliance, United States Pharmacopeia, and International Organization for Standardization guidelines.

INTERPHEX 2019 was held in New York, NY, at the Javits Convention Center from April 2–4, 2019.

Source: Watson-Marlow Fluid Technology

Related to this article

View more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
FDA clears the IND for Biolojic Design’s BD200, an AI-designed Trop2/Nectin-4 multibody ADC; Blackstone Life Sciences agrees to provide Pfizer up to $1.5 billion to develop its monthly GLP-1 receptor agonist berobenatide; and enGene Therapeutics plans a year-end BLA for detalimogene voraplasmid in BCG-unresponsive non-muscle invasive bladder cancer.
Read more